CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1466.70-19.85 (-1.34 %)
PREV CLOSE () 1486.55
OPEN PRICE () 1487.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 34613
TODAY'S LOW / HIGH ()1460.40 1500.30
52 WK LOW / HIGH ()937.2 1638.7
NSE1466.05-20.65 (-1.39 %)
PREV CLOSE() 1486.70
OPEN PRICE () 1486.70
BID PRICE (QTY) 1466.05 (123)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3474806
TODAY'S LOW / HIGH() 1460.55 1501.00
52 WK LOW / HIGH ()937 1638.85
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1993

Management Info :

- Chairman Dilip S Shanghvi - Managing Director

Registered Office :

Address : Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone : 0265- 5515500 / 5515600 / 5515700

Website : www.sunpharma.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
23May Sun Pharmaceutical Industries reports
Sun Pharmaceutical Industries has reported results for fourth quarter (Q..
04May Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that Sun Pharmaceutical Indus..
25Apr Pharma stocks jump amid rise in India’
Stocks related to pharmaceuticals industry were trading higher on the BS..
12Apr USFDA issues OAI status to Sun Pharmac
US Food and Drug Administration (USFDA) has issued Official Action Indic..
28Mar Clarification sought from Sun Pharmac
The Exchange has sought clarification from Sun Pharmaceutical Industries..
Financials
in Millions
QTR Mar 24 ANNUAL 24
Net Profit867628581.8
Gross Profit 14017.8 34496.5
Operating Profit 20124.160533.7
Net Sales 56391.4202751.7
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 6441.05 (7.14%)
M.Cap ( in Cr)
16102.63
Divi's Lab (BSE)
 4254.00 (3.18%)
M.Cap ( in Cr)
112930.33
JB Chem & Pharma (BSE)
 1781.70 (6.79%)
M.Cap ( in Cr)
27652.25
Glenmark Pharma (BSE)
 1120.30 (8.20%)
M.Cap ( in Cr)
31613.54
Pfizer (BSE)
 4552.90 (1.33%)
M.Cap ( in Cr)
20828.48
Shareholding Pattern
PROMOTERS 54.48%
MUTUAL FUNDS/UTI 12.21%
NON-INSTITUTION 8.97%
FI/BANKS/INSURANCE 5.12%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX75390.50-19.89 (-0.03%)
NIFTY22932.45-24.65 (-0.11%)
Dow Jones 39069.594.33 (0.01%)
Nasdaq 16920.79184.76 (1.10%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI